Epidemiology, natural history, and diagnosis of metabolic dysfunction-associated fatty liver disease: a comparative review with nonalcoholic fatty liver disease,Therapeutic Advances in Endocrinology and Metabolism

当前位置： X-MOL 学术 › Ther. Adva. Endocrinol. Metab. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Epidemiology, natural history, and diagnosis of metabolic dysfunction-associated fatty liver disease: a comparative review with nonalcoholic fatty liver disease
Therapeutic Advances in Endocrinology and Metabolism ( IF 3.8 ) Pub Date : 2022-12-10 , DOI: 10.1177/20420188221139650
Eda Kaya _{1,

2} , Yusuf Yilmaz _{3,

4}

Affiliation

Metabolic (dysfunction)-associated fatty liver disease (MAFLD) is the most common chronic liver disease worldwide – with an estimated global prevalence of 37%. Different from nonalcoholic fatty liv...

中文翻译：